Synapse

← Transfusion Alternatives in Transfusion Medicine

Papers in Transfusion Alternatives in Transfusion Medicine

Page 4 · newest first

  1. Fluid Therapy and CoagulationTransfusion Alternatives in Transfusion Medicine · 2003
  2. Hydroxyethyl Starches and Pruritus: A Real Problem?Transfusion Alternatives in Transfusion Medicine · 2003
  3. Fresh Frozen Plasma: Clinical Guidelines and UseTransfusion Alternatives in Transfusion Medicine · 2003
  4. Is the Clinical Significance of Blood Storage Lesions Underestimated?Transfusion Alternatives in Transfusion Medicine · 2003
  5. Anemia, Blood Transfusion, and Clinical Outcomes in Patients With Cardiovascular Risk FactorsTransfusion Alternatives in Transfusion Medicine · 2003
  6. Should We Reconsider Recommendations for Red Blood Cell Transfusion?Transfusion Alternatives in Transfusion Medicine · 2003
  7. ABC Study: The Results and Clinical ApplicationTransfusion Alternatives in Transfusion Medicine · 2003
  8. Can Policy Decisions in Transfusion Medicine Be Evidence‐Based?*Transfusion Alternatives in Transfusion Medicine · 2003
  9. Strength of the Evidence Generated From Reports of Clinical ResearchTransfusion Alternatives in Transfusion Medicine · 2003
  10. Applications of Meta‐Analysis in Transfusion MedicineTransfusion Alternatives in Transfusion Medicine · 2003
  11. The Emerging Dutch Hemovigilance System: Voluntary and State‐of‐the‐ArtTransfusion Alternatives in Transfusion Medicine · 2003
  12. Does the United States of America Have a System for Reporting Serious Hazards of Transfusion?Transfusion Alternatives in Transfusion Medicine · 2003
  13. Disseminated Intravascular CoagulationTransfusion Alternatives in Transfusion Medicine · 2003
  14. Massive Transfusion and CoagulopathyTransfusion Alternatives in Transfusion Medicine · 2003
  15. Perioperative Disorders of Primary Hemostasis: Determination and TreatmentTransfusion Alternatives in Transfusion Medicine · 2003
  16. The Dilemma Between Cost‐Effectiveness and Quality of Care in Transfusion Medicine: The Fiduciary Responsibility of the Physician to the Patient With Regard to Blood Transfusion and Transfusion AlternativesTransfusion Alternatives in Transfusion Medicine · 2002
  17. Decision Analysis in Transfusion Medicine – Practical ConsiderationsTransfusion Alternatives in Transfusion Medicine · 2002
  18. Anemia and Blood Transfusion in the Critically Ill:The Role of ErythropoietinTransfusion Alternatives in Transfusion Medicine · 2002
  19. Hazards of Homologous Blood TransfusionTransfusion Alternatives in Transfusion Medicine · 2002
  20. Anemia in Critically Ill Patients: How Much Can They Tolerate?Transfusion Alternatives in Transfusion Medicine · 2002
  21. Hypertonic Solutions May Prevent Multiple Organ Failure in Humans: Myth or Reality?Transfusion Alternatives in Transfusion Medicine · 2002
  22. Use of Albumin in the Intensive Care UnitTransfusion Alternatives in Transfusion Medicine · 2002
  23. The Effects of Fluid Optimization on Outcome Following Major SurgeryTransfusion Alternatives in Transfusion Medicine · 2002
  24. Using Small‐Volume Resuscitation in Sweden: Observations From Initial ExperiencesTransfusion Alternatives in Transfusion Medicine · 2002
  25. Transfusion‐Related Acute Lung InjuryTransfusion Alternatives in Transfusion Medicine · 2002
  26. Transfusion‐Related Immunomodulation:Transfusion Alternatives in Transfusion Medicine · 2002
  27. Management of the Anemia of Prematurity Using Human Recombinant ErythropoietinTransfusion Alternatives in Transfusion Medicine · 2002
  28. Blood Conservation During Pediatric Cardiac SurgeryTransfusion Alternatives in Transfusion Medicine · 2002
  29. The Changing Transfusion Practice of Neonatal and Pediatric SurgeryTransfusion Alternatives in Transfusion Medicine · 2002
  30. Efficacy of Preoperative Autologous Blood DonationTransfusion Alternatives in Transfusion Medicine · 2001
  31. Is There Still a Place for Autologous Blood Predonation?Transfusion Alternatives in Transfusion Medicine · 2001
  32. Use of the Cell Saver in Oncologic SurgeryTransfusion Alternatives in Transfusion Medicine · 2001
  33. Pharmacological Strategies to Decrease Excessive Blood Loss in Cardiac Surgery: Meta‐analysis of Clinically Relevant Endpoints*Transfusion Alternatives in Transfusion Medicine · 2001
  34. Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in Trauma*Transfusion Alternatives in Transfusion Medicine · 2001
  35. Pharmacological Interventions to Prevent the Need for Blood and Blood Component Therapies:Transfusion Alternatives in Transfusion Medicine · 2001
  36. Lessons from Meta‐analysis: The Case of AlbuminTransfusion Alternatives in Transfusion Medicine · 2001
  37. HES: Is There a Maximal Dose?Transfusion Alternatives in Transfusion Medicine · 2001
  38. Hyperchloremic Metabolic Acidosis: Is It Clinically Relevant?Transfusion Alternatives in Transfusion Medicine · 2001
  39. Autologous Blood Predonation Versus Acute Normovolemic HemodilutionTransfusion Alternatives in Transfusion Medicine · 2000
  40. Efficacy of Autologous Blood PredonationTransfusion Alternatives in Transfusion Medicine · 2000
  41. The Risks of Autologous PredonationTransfusion Alternatives in Transfusion Medicine · 2000
  42. Red Blood Cell Apheresis is a cost‐effective procedure to avoid Allogeneic TransfusionTransfusion Alternatives in Transfusion Medicine · 2000
  43. Practical Limits of Acute Normovolemic Hemodilution Status and Future ProspectsTransfusion Alternatives in Transfusion Medicine · 2000
  44. Transfusion Morbidity and Mortality in the ICUTransfusion Alternatives in Transfusion Medicine · 2000
  45. Transfusion Mortality and Morbidity in Orthopedic SurgeryTransfusion Alternatives in Transfusion Medicine · 2000
  46. Infections Related to Red Cell Transfusions Including Variant Creutzfeldt‐Jakob DiseaseTransfusion Alternatives in Transfusion Medicine · 2000
  47. Current Information on the Benefits of Allogeneic BloodTransfusion Alternatives in Transfusion Medicine · 2000
  48. Risks Associated with Under‐TransfusionTransfusion Alternatives in Transfusion Medicine · 2000
  49. Colloids/Crystalloids J Does Albumin Influence the Mortality Risk?Transfusion Alternatives in Transfusion Medicine · 2000
  50. A New Hydroxyethyl Starch: HES 130/0.4 Voluven®Transfusion Alternatives in Transfusion Medicine · 2000